Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Palliative Care for Inclusion Body Myositis, a Case Report

Kamini E. Kuchinad, MD, MPH, Ambereen Mehta, MD, MPH, David Wu, MD, & Jemima Albayda, MD  |  Issue: September 2024  |  September 7, 2024

Click to enlarge.

During evaluation by his primary care doctor, his lab work demonstrated an elevated creatinine kinase, concerning for ongoing muscle damage, but the etiology of his symptoms was not identified.

Over the next five years, he saw numerous specialists and underwent countless tests while his physical condition deteriorated. He underwent a muscle biopsy that was interpreted as polymyositis and was started on high-dose glucocorticoids for treatment. This failed to make an impact on his muscle strength. He was told not to exercise under the premise of causing further muscle damage, which likely exacerbated his weakness. Due to his progressive symptoms, he presented to the Johns Hopkins Myositis Center for a second opinion and was ultimately diagnosed with IBM based on his clinical history, muscle biopsy and physical exam (see Table 1 and Figures A, B & C).

FIGURE A: Finger flexor weakness in IBM.

By the time he was diagnosed, Mr. F had already experienced significant debility due to his disease and complications of futile high-dose glucocorticoid therapy, including weight gain, diabetes and gastrointestinal perforation.

 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

During the years after his diagnosis, he was hospitalized four times, predominantly for episodes of aspiration pneumonia due to his progressive dysphagia. Because of his myopathy, he left each hospitalization increasingly debilitated. After one hospitalization, he returned home in a wheelchair, representing a loss of function that was never regained.

As his disease progressed, he faced significant psychosocial stressors and his quality of life suffered. A passionate social worker, he was forced to stop working due to the lack of accessible transportation options. With his progressive finger flexor weakness, he lost his ability to play the piano, one of his favorite activities. He began to suffer from depression and anxiety, exacerbated by his declining functional status. He became socially isolated due to shame surrounding his illness and soon became hesitant to even leave his house.

Throughout Mr. F’s illness, his wife was his primary and only care partner. She took ownership of managing his increasing needs. Without any professional guidance or social work support, she learned the complex process of insurance coverage for his different modalities of care. She obtained a fitted wheelchair, a Hoyer lift and a mobility van, and outfitted their apartment to make it accessible.

The day-to-day caregiving became overwhelming for her, both physically and emotionally. She bathed him, helped him with voiding and lifted his 200 lb. body in and out of his wheelchair. She sacrificed her own self-care to care for her husband; when she was forced to take respite for her own medical procedures, she experienced overwhelming feelings of guilt and failure. She no longer knew who she was beyond being a care partner for her husband.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsMyositis Tagged with:case reportEditor's Pickinclusion body myositis (IBM)palliative care

Related Articles

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Myositis Mysteries

    January 1, 2008

    Why isn’t my myositis patient getting better?

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

    Tashatuvango / shutterstock.com

    Myositis-Specific Antibodies Identified

    January 16, 2020

    The idiopathic inflammatory myopathies (IIM) encompass eight categories: 1) dermatomyositis (DM) in adults, 2) juvenile dermatomyositis, 3) amyopathic DM, 4) cancer-associated DM, 5) polymyositis, 6) immune-mediated necrotizing myopathy, 7) inclusion body myositis, and 8) overlap myositis.1 These categories help classify the myopathies based on clinical and histologic features. The incidence of IIM is estimated at…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences